Skip to content
10-Q

Quarterly Report

INTEST CORP INTT

0001036262-26-000032

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 30, 2026 12.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 12.42M sh
Shares Diluted Q1 2026 · Mar 31, 2025 12.18M sh
Capex Q1 2026 · Mar 31, 2026 $644K
Capex Q1 2026 · Mar 31, 2025 $229K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$3.32M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $5.54M
Long Term Debt Q1 2026 · Mar 31, 2026 $1.12M
Long Term Debt Q1 2026 · Dec 31, 2025 $1.41M
Short Term Debt Q1 2026 · Mar 31, 2026 $7.42M
Short Term Debt Q1 2026 · Dec 31, 2025 $6.06M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $12.87M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $14.22M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $22.05M
Stockholders Equity Q1 2026 · Mar 31, 2026 $104.47M
Stockholders Equity Q1 2026 · Dec 31, 2025 $103.62M
Stockholders Equity Q1 2026 · Mar 31, 2025 $99.4M
Stockholders Equity Q1 2026 · Dec 31, 2024 $99.79M
Current Liabilities Q1 2026 · Mar 31, 2026 $35.83M
Current Liabilities Q1 2026 · Dec 31, 2025 $35.76M
Total Liabilities Q1 2026 · Mar 31, 2026 $46.3M
Total Liabilities Q1 2026 · Dec 31, 2025 $47.69M
Current Assets Q1 2026 · Mar 31, 2026 $79.63M
Current Assets Q1 2026 · Dec 31, 2025 $78.64M
Total Assets Q1 2026 · Mar 31, 2026 $150.77M
Total Assets Q1 2026 · Dec 31, 2025 $151.31M
Total Assets Q1 2026 · Mar 31, 2025 $148.03M
Eps Diluted Q1 2026 · Mar 31, 2026 $0.06
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.19
Eps Basic Q1 2026 · Mar 31, 2026 $0.06
Eps Basic Q1 2026 · Mar 31, 2025 −$0.19
Sga Expense Q1 2026 · Mar 31, 2026 $6.12M
Sga Expense Q1 2026 · Mar 31, 2025 $5.82M
Rd Expense Q1 2026 · Mar 31, 2026 $2.59M
Rd Expense Q1 2026 · Mar 31, 2025 $2.45M
Net Income Q1 2026 · Mar 31, 2026 $789K
Net Income Q1 2026 · Mar 31, 2025 −$2.33M
Operating Income Q1 2026 · Mar 31, 2026 $954K
Operating Income Q1 2026 · Mar 31, 2025 −$2.88M
Gross Profit Q1 2026 · Mar 31, 2026 $15.41M
Gross Profit Q1 2026 · Mar 31, 2025 $11.06M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $18.48M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $15.58M